Bayesian Health's TREWS platform, developed at Johns Hopkins, received the first-ever FDA clearance for a continuous AI sepsis monitor on May 12, 2026, after a study found it cut mortality 18% when clinicians acted on its alerts.
The FDA's April 2, 2026 warning letter to Purolea Cosmetics Lab is the agency's first enforcement action to explicitly cite inappropriate AI use, after the company let AI agents draft manufacturing records without human review.
The FDA cleared Anumana's ECG-AI algorithm on April 8, 2026, the first tool authorized to flag cardiac amyloidosis from a standard 12-lead ECG, validated across 25,525 patients with 78.9% sensitivity and 91.2% specificity.
Mercy hospitals in Missouri and Arkansas are piloting an ambient AI tool built into Microsoft Dragon Copilot that documents nursing care by listening in—one nurse says it gave her two hours back in a single shift.
A new UPMC and KLAS Research survey finds 93% of health systems have deployed third-party AI, but only 44% have a dedicated environment to test it—exposing a widening gap between adoption and governance.
Sweden's 105,000-woman MASAI trial found AI-supported mammography reduced aggressive interval cancers, while a $16 million U.S. trial called PRISM now tests the same question nationwide.
Withings' Body Scan 2, on sale in the US since July 2026 for $599.95, reads more than 90 biomarkers to flag hypertension, pre-diabetes and heart rhythm problems, part of a broader company push into reimbursed clinical care.
Garmin's new Connect+ subscription bundles an AI feature called Active Intelligence, built on decades-old Firstbeat physiological modeling, alongside CES 2026's AI food-photo tracking, testing how far a hardware-first brand can push into paid AI coaching.
Samsung's June 2026 Samsung Health overhaul adds four AI-driven metrics, Vitals, Heart Health Score, Daily Cardio Load and Fitness Index, to the Galaxy Watch, aiming to flag real problems instead of flooding wearers with data.
Abbott and Google unveiled a partnership on August 11, 2026 integrating Lingo glucose sensor data with Google's AI Health Coach, targeting 115 million Americans with prediabetes and launching one of the largest real-world metabolic health studies to date.